TrialJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2012

A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease.

Karthik Ananthasubramaniam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.